Back

Dapagliflozin, peptide YY, and weight loss in heart failure with preserved ejection fraction

European Heart Journal

21 August 2024
Organised by: Logo
Read full article
ESC Journals HEART FAILURE Chronic Heart Failure

Contributors

Yogesh N V Reddy
Yogesh N V Reddy

Author

Vojtech Melenovsky
Vojtech Melenovsky

Author

Aneesh K Asokan
Aneesh K Asokan

Author

Martin Haluzik
Martin Haluzik

Author

Rickey E Carter
Rickey E Carter

Author

Sreekumaran Nair
Sreekumaran Nair

Author

Michael D Jensen
Michael D Jensen

Author

Barry A Borlaug
Barry A Borlaug

Author

Mayo Clinic Hospital - St. Mary's Campus Rochester , United States of America

You may be interested in
thumbnail
Webinar
GLP-1 RAs and HFpEF: which HFpEF patients should now be receiving GLP-1 RAs?
15 December 2025
thumbnail
Congress Presentation
Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction, a sub-study of DAPA-VO2.
20 May 2023
thumbnail
Congress Presentation
Effect of SGLT-2 inhibitors on weight loss in HFrEF and HFpEF patients: meta-analysis of 14 thousand participants
20 May 2023
thumbnail
Congress Presentation
Short-term effects of SGLT2 inhibitors on myocardial extracellular volume, left ventricular function and inflammation in patients with HFpEF and diabetes mellitus
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources